| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Monopar Therapeutics | Acting Chief Medical Officer | Stock Option | 2,000 | 01 Jan 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 01 Jan 2026 | 1 | $0 | 4 | Acting Chief Medical Officer | 05 Jan 2026, 15:45 |
| MNPR | Monopar Therapeutics | 01 Jan 2025 | 1 | $0 | 4 | Acting Chief Medical Officer | 02 Jan 2025, 18:16 |
| MNPR | Monopar Therapeutics | 01 Jan 2024 | 1 | $0 | 4 | Acting Chief Medical Officer | 03 Jan 2024, 19:33 |
| MNPR | Monopar Therapeutics | 31 Dec 2022 | 1 | $0 | 4 | Acting Chief Medical Officer | 03 Jan 2023, 14:58 |
| MNPR | Monopar Therapeutics | 01 Jan 2022 | 1 | $0 | 4 | Acting Chief Medical Officer | 04 Jan 2022, 12:47 |